23andMe co-founder Anne Wojcicki is slated to regain control of her DNA-testing company after a nonprofit she controls outbid rivals in a bankruptcy auction. TTAM Research Institute, a nonprofit ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Cofounder and former CEO Anne Wojcicki won a bid to regain control of the company in June. Here's a look at the rise and fall of 23andMe. 23andMe, the startup that helped usher in the era of ...

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ6.60%increase; green up pointing triangle, is poised to regain control of the DNA-testing company after a nonprofit she controls topped ...

WHY IT'S IMPORTANT Co-founder Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron's offer for the DNA-testing company in a ...

A nonprofit run by Anne Wojcicki, the cofounder and ... For a long time, it appeared Wojcicki wouldn’t regain control of the company she left in March. New York-based biotech company Regeneron ...

Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy ...